Deal execution and due diligence
Develop the right investment strategy and enhance deal flow • Profile and screen companies/targets • Devise a plan to approach targets • Independently assess commercial potential
Deal generation
Ongoing valuation
Company monitoring
Exit value maximization
Value capture
Roll over to learn more
Financial Institutions
The study of infectious diseases and vaccines is as complex as the populations and environments they impact. To be competitive, and to navigate this environment with the appropriate balance of agility and proven methodology, tailored solutions at every stage of development are critical. IQVIA’s infectious diseases and vaccines experts expand your knowledge and reach by tapping into the IQVIA CORE™ and a global network of patients and sites.
Identify the best exit alternatives and close deal with the right buyer • Identification and validation of exit alternatives • Vendor due diligence and IM generation support • Access to broad network of potential buyers
Track company and industry performance, reflecting most recent events • Track industry trends, events and markets evolution • Follow company performance and deviations from trend • Identify key launches and assets sales evolution
Own an up to date view on company present and future value • Evaluate company business model and performance vs competitors • Identify historical evolution and future focus areas
Make more valuable and better informed deal decisions • Perform commercial and technical due diligence • Assess performance improvement opportunities • Provide a portfolio/asset valuation
Unlock full company value and identify opportunities for further value enhancement • Define strategy to integrate assets • Drive operational and performance enhancement • Identify and drive cost reduction
Private equity
Public equity
To make smart investments in life sciences you need a deep understanding of scientific innovation and an evidence-based view of a complex and evolving competitive landscape.
To make smart investments in life sciences you need a deep understanding of scientific innovation and an evidence-based view of a complex and evolving competitive landscape
